Measurement of biochemical markers represents an important aid to clinicians in the earlydiagnosis and prognosis of neurological diseases. Many factors can contribute to increase thechances that a biomarker study becomes successful. In a cerebrospinal fluid analysis (CSF),more than 84% of laboratory errors can be attributed to several preanalytical variables thatinclude CSF collection, storage, and freeze thawing cycles. In this concept paper, we focus onsome critical issues arising from basic proteomics investigation in order to highlight somekey elements of CSF quality control. Furthermore, we propose a direct assessment of samplequality (DASQ) by applying a fast MALDI-TOF-MS methodology to evaluate molecular featuresof sample degradation and oxidation. We propose DASQ as a fast and simple initial step to beincluded in large-scale projects for neurological biomarker studies. In fact, such a procedurewill improved the development of standardized protocols in order to have well-characterizedCSF biobanks.

Direct analytical sample quality assessment for biomarker investigation : qualifying cerebrospinal fluid samples / V. Greco, D. Pieragostino, C. Piras, R. Aebersold, J. Wiltfang, C. Caltagirone, S. Bernardini, A. Urbani. - In: PROTEOMICS. - ISSN 1615-9853. - 14:17-18(2014), pp. 1954-1962. [10.1002/pmic.201300565]

Direct analytical sample quality assessment for biomarker investigation : qualifying cerebrospinal fluid samples

C. Piras;
2014

Abstract

Measurement of biochemical markers represents an important aid to clinicians in the earlydiagnosis and prognosis of neurological diseases. Many factors can contribute to increase thechances that a biomarker study becomes successful. In a cerebrospinal fluid analysis (CSF),more than 84% of laboratory errors can be attributed to several preanalytical variables thatinclude CSF collection, storage, and freeze thawing cycles. In this concept paper, we focus onsome critical issues arising from basic proteomics investigation in order to highlight somekey elements of CSF quality control. Furthermore, we propose a direct assessment of samplequality (DASQ) by applying a fast MALDI-TOF-MS methodology to evaluate molecular featuresof sample degradation and oxidation. We propose DASQ as a fast and simple initial step to beincluded in large-scale projects for neurological biomarker studies. In fact, such a procedurewill improved the development of standardized protocols in order to have well-characterizedCSF biobanks.
Biomarkers; Biomedicine; Cerebrospinal fluid; MALDI-TOF-MS; Neurodegenerative diseases; Sample quality control; Biological Markers; Clinical Chemistry Tests; Humans; Neurodegenerative Diseases; Quality Control; Specimen Handling; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Molecular Biology; Biochemistry; Medicine (all)
Settore VET/05 - Malattie Infettive degli Animali Domestici
Settore MED/07 - Microbiologia e Microbiologia Clinica
Article (author)
File in questo prodotto:
File Dimensione Formato  
Greco_et_al-2014-PROTEOMICS.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 442.23 kB
Formato Adobe PDF
442.23 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/339862
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 17
social impact